Emerald Bioscience Announces Financing Update and Board Re-organization
23 déc. 2019 08h30 HE
|
Emerald Bioscience, Inc.
Emerald Health Sciences To Exercise 40.8 Million Warrants, Reducing Outstanding Debt, As Company Changes Name to Embi Pharmaceuticals Punit Dhillon Assumes Board Chairmanship as Dr. Avtar Dhillon...